Product Liability Regulation, Legislation To Watch: 2021

By Emily Field (January 3, 2022, 12:03 PM EST) -- What's old is new again, as a previous U.S. Food and Drug Administration commissioner is poised to lead the agency again and attorneys are anticipating that improving clinical trials will be among his top priorities. And more legislation has been introduced to legalize marijuana on the federal level and allow CBD to be marketed in foods as well. Here's what to watch on the legislative and regulatory fronts in 2022.

A Potential New Head at FDA

Long past the usual timeline for a new administration to announce a nomination to lead the FDA, the White House in mid-November said it had...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!